ライフサイエンスコーパス: stay

1 ty, need for ICU admission, or ICU length of stay.

2 5% of recommended doses during the inpatient stay.

3 ciated with a reduction of the ICU length of stay.

4 llness, need for vasopressors, and length of stay.

5 o functional recovery and length of hospital stay.

6 testinal symptoms and the length of hospital stay.

7 ty, any reported AE, mortality and length of stay.

8 erative complications and a shorter hospital stay.

9 roup, treatment intensity, and length of ICU stay.

10 nd might decrease overall hospital length of stay.

11 including reduced complications and hospital stay.

12 usted mortality, readmissions, or lengths of stay.

13 5% CI, 1.42 to 2.14), and length of hospital stay.

14 lmonary complications and length of hospital stay.

15 ive care unit (ICU) admission, and length of stay.

16 he mean time to full feeds and mean hospital stay.

17 ori chosen primary outcome was ICU length of stay.

18 s with secondary infections during their ICU stay.

19 es except for a marginally shorter length of stay.

20 gth of intensive care unit stay and hospital stay.

21 ges in mortality, readmissions, or length of stay.

22 rtality and death or prolonged ICU length of stay.

23 nts who were admitted had shorter lengths of stay.

24 n (27%) developed delirium during their PICU stay.

25 ion, reoperation, readmission, and length of stay.

26 , without subsequent difference in length of stay.

27 -6, IL-10, C-reactive protein, and length of stay.

28 with improved outcomes and shorter length of stay.

29 ased mortality and longer hospital length of stay.

30 e infection, and ICU and hospital lengths of stay.

31 ed on insurance type, and hospital length of stay.

32 on clinical information available during ICU stay.

33 ajority of COVID-19 patients during hospital stay.

34 r mortality and prolonged length of hospital stay.

35 care units regardless of patients' length of stay.

36 ntinued to decline with increasing length of stay.

37 ment in care of the patient during their ICU stay.

38 0.37-0.80), but prolonged ICU- and hospital stays.

39 A cohort of inpatient operations (length of stay 1 day or greater) was obtained from a consortium of

40 296] vs 33.5% [n/N = 779/2322]) and hospital stays (1.7% [n/N = 5/296] vs 24.2% [n/N = 561/2322]) red

41 major complications (n=1539), and length of stay (101 183 days) over the 4-year study period if all

42 d major bleeding had longer median length of stay (11 vs 6 d; p = 0.02), and higher total costs than

43 reactivation was associated with longer ICU stay (12.9 vs 9.2 days; p = 0.004) and increased organ f

44 hemodynamic instability = 70%; hospital/ICU stay = 12 d; mortality = 14%) were transferred urgently

45 ion (38.0% vs 56.7%; P < .01), and length of stay (14.5 +/- 14.9 vs 22.6 +/- 19.0 days; P < .01).

46 - 2.1 vs 4.1 +/- 2.5; P < .01) and length of stay (18.6 +/- 17.5 vs 28.2 +/- 17.7; P < .01).

47 7+ consecutive days (adjusted ICU length of stay = 2.85 d), care by an intensivist working 3 or fewe

48 timated blood loss 50 (32) mL, and length of stay 3 (1) days.

49 ys was associated with shorter ICU length of stay (3 consecutive days: 0.46 d fewer, p = 0.010; 2 con

50 patients had shorter mean hospital length of stay (3.1 vs 5.4 d, P < 0.01) and had fewer unplanned re

51 ty (17.5% vs 9.8%; P<0.001), longer hospital stay [3 (1-7) vs 2 (1-5) days; P = 0.021], and more psyc

52 s cycle threshold values; length of hospital stay; 30-day mortality; and whether the InfA infection m

53 group; P = .004), and a shorter in-hospital stay (34 days [IQR 18-55] vs 51 days [IQR 35-91] in posi

54 The index case stayed 4 days in the chalet with 10 English tourists and

55 Length of stay (6.5 versus 3.2 days, P < 0.01), readmission rate (

56 ith previous HF experienced longer length of stay (8 days vs. 6 days; p < 0.001), increased risk of m

57 36), as well as a shorter length of hospital stay (8.9 vs. 12.5 days; p = 0.015).

58 An increasing length of stay (adjusted odds ratio [aOR] per day, 1.03; P = .006)

59 , readmission to ICU, and length of hospital stay after ICU discharge.Methods: Data were accessed fro

60 Reducing length of stay after kidney transplant has an unknown effect on po

61 lockage, while that of the blue emissive CDs stayed almost constant, which led to an obvious change i

62 The median length of stay among patients with acute coronary syndrome fell fr

63 ser benefits for ThuVARP of reduced hospital stay and complications were not observed.

64 gnificantly associated with longer length of stay and cost.

65 CU readmission, increased hospital length of stay and death and are not predicted by ICU or ward phys

66 l ventilation, length of intensive care unit stay and hospital stay.

67 h care costs, because of increased length of stay and increased frequency of readmissions due to recu

68 a and influenza hospitalizations among short-stay and long-stay long-term care facility residents in

69 oup and enhanced in patients with longer ICU stay and lower Acute Physiology and Chronic Health Evalu

70 ncreases in IL-6:AAT predicted prolonged ICU stay and mortality, whereas improvement in IL-6:AAT was

71 f enteral feeds to be beneficial to hospital stay and patient outcomes.

72 Other collected variables included length of stay and primary diagnosis on admission.

73 Secondary endpoints were the ICU length of stay and the 28-day all-cause mortality.

74 The hospital stay and time to the first meal were shorter in the PLDR

75 ry was associated with increased duration of stay and ventilation.

76 Overall, 12% of AGE inpatient cases had ICU stays and 2% died; 3 deaths were associated with C. diff

77 harged home and necessitated longer hospital stays and greater hospitalization charges.

78 Metastatic complications, length of stay, and 30-day mortality were progressively worse as b

79 lity, quality-adjusted life-years, length of stay, and costs of care.

80 tient mortality, discharge status, length of stay, and costs.

81 term mortality, clinical outcomes, length of stay, and discharge disposition to home.

82 Outcomes were mortality, hospital length of stay, and discharge disposition.

83 ry support, hospitalization costs, length of stay, and discharge disposition.

84 patient care, management, length of hospital stay, and efficient use of hospital resources.

85 had higher case-fatality, longer lengths of stay, and higher costs than patients who had only blood

86 ciated with longer median hospital length of stay, and higher mean costs.

87 sion, acute kidney injury, stroke, length of stay, and hospital costs).

88 ansfusion, vascular complications, length of stay, and hospital costs.

89 admission volume, home health use, length of stay, and hospital use within 90 days of SNF admission.

90 care unit length of stay, hospital length of stay, and in-hospital mortality.

91 d renal clearance on the next day during ICU stay, and made it available via an online calculator.

92 ential to reduce antibiotic usage, length of stay, and patient charges.

93 inpatient opioid use, pain scores, length of stay, and patient-reported quality of life.

94 0 mm visual analog scale, length of hospital stay, and patient-reported quality of life.

95 asured complications and severity, length of stay, and readmissions.

96 ation, PaCO2 after intubation, ICU length of stay, and short-term mortality.

97 ength of stay, intensive care unit length of stay, and ventilator days) did not differ between groups

98 .0-23.6 d] vs 10.8 d [5.9-20.3 d]) length of stay, and were more likely to die in the ICU (12.3% vs 7

99 urations of intensive care unit and hospital stays, and all-cause mortality at postoperative days 28

100 ical ventilation, length of ICU and hospital stays, and doses of sedative and analgesic drugs adminis

101 was associated with shorter hospital and ICU stays, and shorter duration and need for mechanical vent

102 ts (emergency department visits, observation stays, and unplanned inpatient admissions) within 7 days

103 sleep disturbances (eg, trouble falling and staying asleep).

104 kers such as healthcare staff are advised to stay at home if they or household members experience cor

105 Governors' recommendations for residents to stay at home preceded stay-at-home orders and led to a s

106 ), longer hospitalization (p=0.015), and ICU stay at transplantation (p=0.029) were significantly ass

107 Stay-at-home orders (lockdowns) have been deployed globa

108 tions for residents to stay at home preceded stay-at-home orders and led to a significant reduction i

109 stigated sleep behaviors prior to and during Stay-at-Home orders in 139 university students (aged 22.

110 roving sleep health during and following the Stay-at-Home orders of the COVID-19 pandemic.

111 The additional effect of stay-at-home orders was comparatively small.

112 gap strengthened over time and remained when stay-at-home orders were active.

113 eady or are considering to re-open and relax stay-at-home orders, there remains a continued need for

114 statewide physical distancing guidelines and stay-at-home orders.

115 ng businesses or educational institutions to stay-at-home orders.

116 ncreased from 84% to 92% for weekdays during Stay-at-Home versus baseline.

117 During Stay-at-Home, nightly time in bed devoted to sleep (TIB,

118 increases in weekday and weekend TIB during Stay-at-Home.

119 the sample, while keeping it cool enough to stay below the melt curve.

120 in major morbidity, mortality, and hospital stay between MIPD and OPD.

121 han half of the revisit-associated length of stay burden from all procedures, with the highest relati

122 , IDR 3.1 [95% CrI 2.5-3.7]), mean length of stay by 1.8-fold (19.2 versus 10.5 days, IDR 1.8 [95% Cr

123 risk of mortality, graft loss, and length of stay by recurrent falls before KT using adjusted regress

124 ot seeking or delaying medical care so as to stay by their infant.

125 of mechanical ventilation, or ICU length of stay by timing of intubation.

126 at the wintering grounds has reduced ('short-staying') by ~38 days since 1989.

127 $208 577; P<0.001) but comparable lengths of stay compared with men.

128 ces bleeding, ventilator time, and length of stay compared with traditional CABG.

129 n ED dwell time, ICU and hospital lengths of stay, complications, and in-hospital mortality.

130 nificantly larger magnitude, and essentially stays constant at ~0.22% and ~0.20% for MAPbI(3) and (BA

131 tation costs and length and cost of hospital stay, costs of warming blanket use, blood transfusions a

132 Mortality and length of stay decreased in the post-Affordable Care Act period wi

133 Length of hospital stay did not differ significantly after the policy chang

134 The liberated RNAP can either stay dormant, sequestered by HelD, or upon HelD release,

135 were ICU length of stay, hospital length of stay, duration of mechanical ventilation, use of renal r

136 ED length of stay (ED-LOS); ICU length of stay (ICU-LOS); hospital le

137 e enrolled in ADAP-funded QHPs, ADAP clients stay enrolled.

138 LC does not stay fixed at the OP once the cell cycle begins and repl

139 tly lower than predicted throughout hospital stay for all gestation groups when compared with UK1990

140 The mean length of stay for readmitted patients was significantly longer th

141 -day case fatality rates, and mean length of stay for stroke, ischaemic heart disease, and any cause

142 er static cold storage, MP is likely here to stay for the foreseeable future.

143 We followed 1118 women (234 SWAD and 884 STAY) for a mean of 2.0 years (+/- 0.1 standard deviatio

144 patients, 18 years old or older, with an ICU stay greater than 24 hours, who were on a ventilator for

145 composite outcome of death or ICU length of stay greater than 48 hours, the risk model consisting of

146 ermostability (MT), rate of senescence (RS), stay green trait (SGT), and NDVI values were collected a

147 Promoter variations in the Stay-Green (OsSGR) gene encoding the chlorophyll-degradi

148 lerance of adult rice plants through visual (stay-green) and chlorophyll fluorescence ( PSII) approac

149 up) were compared to women on non-INSTI ART (STAY group).

150 on models compared changes over time by SWAD/STAY group, adjusted for age, race, WIHS site, education

151 On average, compared to the STAY group, the SWAD group experienced mean greater incr

152 ears, non-alcoholic cirrhosis, and length of stay > 10 days were significant predictor of calendar ye

153 d a higher percentage of prolonged length of stay >14 days (9.3% versus 2.4%, P=0.006), prolonged ven

154 tal of 1,047 adult hospital patients, with a stay >= 24 h were randomly selected.

155 risk factors (age, sex, BCG-vaccination and stays >=3 months in Africa/Asia).

156 The oxidation rates of specific proteins stayed highly consistent with bactericidal rates and thu

157 length of stay (ICU-LOS); hospital length of stay (HLOS); complications; and in-hospital mortality we

158 were only associated with small increases in staying home in low-income neighbourhoods.

159 , infections, compliance and the duration of stay-home order.

160 ancing strategies and in the duration of the stay-home order.

161 nse team call, intensive care unit length of stay, hospital length of stay, and in-hospital mortality

162 Secondary outcomes were ICU length of stay, hospital length of stay, duration of mechanical ve

163 ED length of stay (ED-LOS); ICU length of stay (ICU-LOS); hospital length of stay (HLOS); complica

164 condary outcomes included hospital length of stay, ICU readmissions, and mortality (ICU and hospital)

165 utcomes included ICU and hospital lengths of stay; ICU, hospital, and 28- and 90-day mortality; devel

166 The two polyP regions within the PRD stay in a polyP II helix for most of the simulation, whe

167 onors characterized by prolonged duration of stay in an intensive care unit (ICU) and increased numbe

168 al prophylaxis upon the first day of the ICU stay in comatose patients with severe brain injury could

169 The duration of hospital stay in days was shorter in the SC in comparison with th

170 umatic AKI-RRT patients had longer length of stay in hospital [median (IQR):15 (5-34) days vs. 6 (3-1

171 ergoing surgery requiring at least a 1-night stay in hospital.

172 ittently bloody diarrhea during a five month stay in Indonesia seven years prior to admission.

173 We found that mice are more likely to stay in places paired with orexin cell optosilencing.

174 They were also less likely to stay in the hospital for more than one day [26.4% vs.30.

175 heobronchitis was lower, and the duration of stay in the hospital shorter, in the intervention group

176 three- to sixfold from >=6 days' duration of stay in the ICU onwards.

177 nate was associated with a shorter length of stay in the ICU, which supports the actual therapeutic t

178 ce the time on ventilation and the length of stay in the intensive care unit (ICU).

179 om longitudinal recordings during the baby's stay in the Neonatal Intensive Care Unit.

180 ent for Pediatric Delirium) throughout their stay in the PICU.

181 f implementation in tobacco control, and who stayed in surgical units had higher expectations of rece

182 non-safe microcapsule dose leads to carriers staying in glomeruli for at least 48 h which has consequ

183 uld benefit-improve postfledging survival-by staying in the nest longer: Why then do they fledge so e

184 ondary endpoints included length of hospital stay, in-hospital mortality and adverse events.

185 ciated with significant changes in length of stay (incidence rate ratio, 1.02; 95% confidence interva

186 primary outcome was total length of hospital stay including re-admission up to 30 days after randomis

187 aluation of in-hospital mortality, length of stay, infusion-related reactions, and thrombotic event o

188 To prevent prolonged hospital stay, initiatives should in addition focus on delayed ga

189 ls break during polymerization, while others stay intact.

190 ables (in-hospital death, hospital length of stay, intensive care unit length of stay, and ventilator

191 tation-related mortality; length of hospital stay; intensive care unit admissions; acute graft-versus

192 a hospitalizations among short-stay and long-stay long-term care facility residents in the United Sta

193 e were 13 114 UABSIs in 1.8% of patients who stayed longer than 48 hours on ICU.

194 uma patients who require intensive care unit stays longer than 5 days with ongoing organ dysfunction.

195 Although length of stay (LoS) after childbirth has been diminishing in seve

196 verse clinical outcomes [increased length of stay (LOS) and complications] in complex pediatric patie

197 arge, which could prolong hospital length of stay (LOS) and increase financial burden.

198 shown to be associated to hospital length of stay (LOS) and mortality.

199 Studies estimating excess length of stay (LOS) attributable to nosocomial infections have fa

200 fication (RTN) have shown improved length of stay (LOS) in bacteremia.

201 GF) using logistic regression, and length of stay (LOS) using negative binomial regression.

202 linical details, outcome, length of hospital stay (LOS), and costs.

203 ility (primary); safety incidents, length of stay (LOS), and institutional discharge (secondary); eas

204 onsumption, in-hospital mortality, length of stay (LOS), and the incidence of Clostridioidesdifficile

205 Primary outcomes included lengths of stay (LOS), antibiotic usage, and relapse incidences.

206 y and clinical outcomes, including length of stay (LOS), duration of respiratory support, respiratory

207 le and adipose tissue and hospital length of stay (LOS), number of any postoperative complications, a

208 nce in clinical severity, hospital length of stay (LOS), rate of functional independence (29.5% vs. 2

209 bution to patient flow in terms of length of stay (LOS), triage time, and other associated performanc

210 do >=3 complications, and length of hospital stay (LOS).

211 ated with higher body mass, longer length of stay, lower Braden score, pressure injury prevention met

212 5; 95% CI, 2.4-13.0), have a longer hospital stay (mean difference, 16.1 d; 95% CI, 8.4-23.7) or die

213 s vs 4 days, p < 0.001) and a higher cost of stay (median $14,241.14 vs $10,472.54, p < 0.001).

214 idney injury was associated with longer PICU stay (median 5 days [interquartile range, 4-7 d] vs 3 da

215 were more likely to have a longer length of stay (median 5 days vs 4 days, p < 0.001) and a higher c

216 ed ventilator-assisted pneumonia, median ICU stay, median hospital stay, mortality rates, and ICU and

217 -flow nasal cannula may reduce ICU length of stay (moderate certainty) and hospital length of stay (m

218 (moderate certainty) and hospital length of stay (moderate certainty) compared with noninvasive vent

219 pneumonia, median ICU stay, median hospital stay, mortality rates, and ICU and hospital costs were e

220 Studies addressed interventions during ICU stay (n = 6), during the post-ICU period (n = 4), or bot

221 t are not directly fluid dynamical (e.g., to stay near surfaces where the concentration of bacterial

222 ical characteristics and outcomes (length of stay, need for intensive care unit, mechanical ventilati

223 03) and is associated with a longer hospital stay (odds ratio = 0.92; P < .001).

224 s also associated with a prolonged length of stay (odds ratio, 1.85; 1.49-2.29) and, after adjustment

225 95% CI, 5.9-18.1), suffer prolonged hospital stay (odds ratio, 4.4; 95% CI, 3.0-6.4), and die in hosp

226 an, 48% [1054/2206]), with a median hospital stay of 5 days (IQR, 3-7).

227 Over a median hospital length of stay of 7 days (interquartile range, 3 to 14 days), 533

228 l events, he was discharged after a hospital stay of almost 1 year.

229 requiring procedures, had a median length of stay of only 3 days, but still incurred both substantial

230 , and increase the chances that the lab will stay on its trajectory?

231 sity is perceived, and how long the ROS wave stays "on" during this process are, however, unknown.

232 Local news outlets have struggled to stay open in the more competitive market of digital medi

233 e music on medication requirement, length of stay or costs in adult surgical patients were eligible.

234 ncidence, prevalence, attributable length of stay or healthcare cost due to hospital-acquired pressur

235 [OR, 0.82 (95% CI, 0.57-1.2)], and length of stay [OR, 0.99 (95% CI, 0.86-1.1)] compared to the histo

236 ffect on postintubation PaCO2, ICU length of stay, or 28-day mortality.

237 es in patient selection, payments, length of stay, or clinical outcomes.

238 ons, apneic time, oxygenation, ICU length of stay, or overall survival when used in the peri-intubati

239 utrition, and an extended hospital length of stay (P < 0.05).

240 , with comparable measurement time points in STAY participants.

241 (RR 0.43, 95% CI: 0.32-0.59), and length of stay (pooled mean difference -2.01, 95% CI: -2.99 to 1.1

242 No significant reduction in length of stay (pooled SMD -0.18 [95% CI -0.43 to 0.067], P = 0.15

243 significantly reduces the length of hospital stay, postoperative serum bilirubin and PT-INR, as well

244 ental variability can lead to dispersal: why stay put if it is better elsewhere?

245 n-urgent for 362 (90%), and median length of stay [Q1, Q3] was 5.1 days [1.9, 9.9].

246 The attributable length of stay ranged from 0.9 to 14.1 days and the attributable c

247 r disease score >=40, postoperative hospital stays, rejection, and nonanastomotic biliary strictures

248 m grows, conservation will have to evolve to stay relevant in the age global change-induced human inf

249 luded hospitalization, intubation, prolonged stay, sepsis, and death.

250 s of the screening tools, length of hospital stay, serum albumin and cholesterol concentrations, lymp

251 08, 95% CI 2.66 to 17.50, p=0.010), while it stayed similar in pain-free patients (Deltamean=2.74, 95

252 as calculated by vector astigmatism analysis stayed stable at 1 month, 3 months, and 1 year.

253 s also led to a reduction in total length of stay (synbiotics weighted mean difference: -3.89; 95% CI

254 For species to stay temporally tuned to their environment, they use cue

255 This suggests that an inpatient stay that included a sepsis code not only identifies ben

256 21-2.80, p = 0.005, I2 = 100%), had hospital stays that were increased by 0.59 days (pooled standardi

257 e impaired eGFR, CKD stage is more likely to stay the same or improve than worsen.

258 t 18-months, two patients improved and three stayed the same.

259 is; however, the magnitude of the anisotropy stays the same despite the large lattice distortion.

260 However, the vesicle size stays tunable by the glycyrrhizin content and increases

261 t risk for mortality and prolonged length of stay using the Pediatric Heart Network Single Ventricle

262 the outcomes of interests were ICU length of stay, vasopressor-free days, ventilation-free days, and

263 rate), to determine the opportunity cost of staying versus leaving.

264 The median hospital stay was 1 to 9 days across specialties.Postoperatively,

265 The median ICU length of stay was 1.57 days (interquartile range, 0.82-2.97 d).

266 ICU length of stay was 13 days (7-21 d) and mortality at 28 days was 2

267 days (range, 9-11); the mean duration of ICU stay was 13 days (range, 10-16).

268 The median hospital stay was 15 days (range: 3-236).

269 femoral access increased to 95.3%, hospital stay was 2 days, and 90.3% were discharged home.

270 ients in the United States, median length of stay was 4 days shorter and 30-day hospital readmission

271 The length of hospital stay was 5 days in the EOR group and 8 days in the UOR g

272 The median length of hospital stay was 6 days.

273 The duration of ICU stay was 7 (5-14) in the control group and 9 (5-20) days

274 n postoperative length of hospital length of stay was 8 days, with the majority of patients discharge

275 valuated whether lift use during a patient's stay was correlated with an increased likelihood of bein

276 Median length of stay was increased after birth in ASD (+ 6.5 h, p < 0.00

277 ed to the baseline period, the ICU length of stay was reduced by 3.2 days in the intervention group (

278 Length of stay was reported as median and interquartile range for

279 and emergency cases, and a reduced length of stay was seen for such patients.

280 on: 182/311 [58.5%]; P = .03), and length of stay was shorter (control: 30 hours [interquartile range

281 Median length of stay was shorter and hospital costs higher with endovasc

282 Median length of stay was significantly lower in LB group (2.0 versus 3.0

283 al illness cutoff (90th percentile length of stay) was greater than or equal to 35 and greater than o

284 es, such as hospital mortality and length of stay, was analyzed.

285 For each patient's ICU stay, we searched the chart for terms that indicated tha

286 intensive care unit and hospital lengths of stay were 2.0 and 6.0 days, respectively.

287 esults for prediction of prolonged length of stay were 85 +/- 3% accuracy and AUROC 0.94 +/- 0.04.

288 -14.0 d); and durations of PICU and hospital stay were 9.4 days (5.6-15.4 d) and 15.7 days (9.2-26.0

289 CONUT and length of stay were both predictive for the number of complication

290 lications and prolonged (>=6 days) length of stay were built.

291 d mycologic data at admission and during ICU stay were collected in a database to evaluate variables

292 r complications, and postoperative length of stay were evaluated using Bayesian models.

293 le infection and ICU and hospital lengths of stay were not significantly different by treatment group

294 the length of mechanical ventilation and ICU stay were only significant for the protocolized physical

295 tive morbidity (Dindo-Clavien >3b), hospital stay were similar in both groups.

296 cases with concurrent or prior year facility stays were identified; cases were attributed mostly to a

297 splantation and prolonged length of hospital stay with the purpose of assisting clinicians and patien

298 ed postoperative ileus, and shorter hospital stays with fewer readmissions.

299 RHD3 to pull an ER tubule toward another and stays with the newly formed 3-way junction of the ER for

300 The two parameters stay within 3.2 +/- 0.2 elementary charges and 30 +/- 2